ALBT — Avalon Globocare Income Statement
0.000.00%
Last trade - 00:00- $3.06m
- $30.71m
- $1.26m
Annual income statement for Avalon Globocare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.55 | 1.38 | 1.39 | 1.2 | 1.26 |
| Cost of Revenue | |||||
| Gross Profit | 0.34 | 0.39 | 0.415 | 0.273 | 0.238 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 20.9 | 13.8 | 10.2 | 10 | 16.8 |
| Operating Profit | -19.4 | -12.5 | -8.83 | -8.79 | -15.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.1 | -12.7 | -9.09 | -11.9 | -16.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -18.1 | -12.7 | -9.09 | -11.9 | -16.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -18.1 | -12.7 | -9.09 | -11.9 | -16.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18.1 | -12.7 | -9.09 | -11.9 | -16.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.41 | -23.9 | -13.6 | -17 | -24.1 |